Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Comorbidities in Myasthenia Gravis

Identifying the most common associations

Publish date:: December 18, 2015

Comorbidities are frequent in patients with myasthenia gravis (MG) and they might worsen the prognosis of MG, according to a study of 253 patients with MG. Researchers found:

• Comorbidities were found in 73% of patients.

• Most frequent associated disorders included: dyslipidemia, thyroid disease, diabetes, hypertension, and other autoimmune conditions.

• Patients with MG and thyoma, diabetes, dyslipidemia, dysthyroidism, and/or hypertension had higher rates of emergency room visits and myasthenic crises, and they required higher doses of drugs.

Citation: Diaz BC, Flores-Gavilán P, García-Ramos G, Lorenzana-Mendoza NA. Myasthenia gravis and its comorbidities. J Neurol Neurophysiol. 6:317. doi:10.4172/2155-9562.1000317.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,